Mitochondrial cardiolipin sequestration of caspofungin underlies Cryptococcus neoformans inherent resistance and may contribute to cardiotoxicity
Authors:
- Anna K. LoksztejnALAnna K. Loksztejn
- Rajendra UpadhyaRURajendra Upadhya
- Eduardo A. CaroECEduardo A. Caro
- David M. GoodenDGDavid M. Gooden
- Adi YonaAYAdi Yona
- Porter K. EllisPEPorter K. Ellis
- Micha FridmanMFMicha Fridman
- Maria A. SchumacherMSMaria A. Schumacher
- Richard G. BrennanRBRichard G. Brennan
- Maureen J. DonlinMDMaureen J. Donlin
- Jennifer K. LodgeJLJennifer K. Lodge
Preprint
Abstract
Cryptococcus exhibits inherent resistance to the echinocandin, caspofungin, which inhibits the synthesis of (1,3)-β-D-glucan, a key component of the polysaccharide cell wall. The essential FKS1 gene encodes the catalytic subunit of (1,3)-β-D-glucan synthase and caspofungin effectively inhibits its activity in vitro, yet the drug remains ineffective against Cryptococcus, suggesting mechanisms beyond target insensitivity. The underlying mechanisms of caspofungin resistance remain unknown, although altered regulation of cell-wall remodeling genes, plasma membrane modifications, drug efflux pathways, and melanin biosynthesis have been suggested. Using boron dipyrromethene (BD-) and fluorescein (F-) labelled caspofungin, we demonstrate that caspofungin enters the cryptococcal cell and primarily accumulates in the mitochondrial inner membrane rather than the plasma membrane. We further establish that this mitochondrial accumulation is driven by a specific interaction between caspofungin and cardiolipin, a phospholipid found in mitochondrial membranes. We demonstrate that this unforeseen localization indicates that mitochondrial sequestration diminishes the effective drug concentrations at the intended target. Notably, the interaction between caspofungin and cardiolipin also takes place in human cells, establishing a mechanistic connection to caspofungin-related cardiotoxicity. Our findings reveal a previously unrecognized mechanism of echinocandin resistance in Cryptococcus and emphasize cardiolipin as an important factor in caspofungin effectiveness.Keywords
Funding Information
- National Science Foundation Graduate Research Fellowship Program (DGE 2139754)
This publication has 49 references indexed in Scilit:
- Antifungal echinocandins: Historical discovery, comprehensive structure-activity relationships, resistance mechanisms and future developmentsEuropean Journal of Medicinal Chemistry, 2025
- CryptococcusCurrent Biology, 2025
- Illuminating antifungal mode of action and resistance with fluorescent probesCurrent Opinion in Chemical Biology, 2025
- Cardiolipin remodeling maintains the inner mitochondrial membrane in cells with saturated lipidomesJournal of Lipid Research, 2024
- Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated ResistanceAngewandte Chemie International Edition, 2024
- Establishment of a platform for measuring mitochondrial oxygen consumption rate for cardiac mitochondrial toxicityToxicological Research, 2022
- Fungicidal Drugs Induce a Common Oxidative-Damage Cellular Death PathwayCell Reports, 2013
- Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)Diagnostic Microbiology and Infectious Disease, 2011
- Cryptococcus neoformans, a fungus under stressCurrent Opinion in Microbiology, 2007
- Fluorescent determination of cardiolipin using 10-N-nonyl acridine orangeAnalytical and Bioanalytical Chemistry, 2007